My Shatak

Empowering You to Feel Your Best Every Day

EECP Therapy may provide gentle, non-invasive support to heart function and overall well-being, potentially helping to:

Porttitor ornare fermentum aliquam pharetra ut facilisis gravida risus suscipit. dui feugiat fusce conubia ridiculus tristique parturient natoque vulputate risu.

Increase oxygen supply to the heart:
EECP can help in promoting the growth of small blood vessels around blocked arteries by enhancing blood flow and pressure. This helps improve oxygen delivery to the heart muscle and may lower its workload.

Reduce chest pain and related symptoms:
Studies have shown that EECP can reduce angina symptoms, decrease nitrate usage, and enhance exercise tolerance in patients with refractory angina.

Improve the ability to exercise:
EECP improves how long and how well patients with ischaemic heart failure can tolerate physical activity. It also helps in reducing fatigue and breathlessness during exercise.

Reduce reliance on medications:
Several studies have shown that EECP therapy helps relieve angina symptoms and reduces dependence on nitroglycerin for chest pain, thereby improving quality of life in patients with symptomatic stable angina.

Avoid hospitalisation:
EECP therapy is associated with reduced rates of hospital admissions due to fewer angina-related events and improved cardiac stability.

Together, these effects help in reducing chest pain, improving the ability to exercise, and enhancing the overall quality of life without surgery or drugs.

Reference.

1. He, X., et al. (2024). Enhanced external counterpulsation in cardiac rehabilitation in patients with coronary heart disease: A literature review. Cardiology Plus, 9(2), 111–119.

2. Ambari, A. M., et al. (2021). External counterpulsation improves angiogenesis by preserving vascular endothelial growth factor-A and vascular endothelial growth factor receptor-2 but not regulating microRNA-92a expression in patients with refractory angina. Frontiers in Cardiovascular Medicine, 8, 761112.

3. Xu, L., et al. (2023). The Effect of EECP on Ischemic Heart Failure: a Systematic Review. Current cardiology reports, 25(10), 1291–1298.

4. Caceres, J., et al. (2021). Enhanced external counterpulsation: A unique treatment for the “No-Option” refractory angina patient. Journal of Clinical Pharmacy and Therapeutics, 46(2), 295-303.

5. Akula, A., et al. (2024). Enhanced External Counterpulsation Outcomes Study: Retrospective Analyses of Data Obtained from Patients at a Single Medical Center in United States. The International journal of angiology : official publication of the International College of Angiology, Inc, 33(3), 182–188.